Invivyd Newsroom

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $3.55

Moomoo NewsNov 20 09:31 ET

Invivyd Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 20 07:05 ET

HC Wainwright & Co. Maintains Buy on Invivyd, Lowers Price Target to $10

BenzingaNov 20 06:55 ET

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Cuts Target Price to $3.55

Moomoo NewsNov 20 06:32 ET

Invivyd's Resilient Strategy and Prospective Growth: Buy Rating Affirmed Amidst Pemgarda Setbacks and New Antibody Developments

TipRanksNov 20 06:18 ET

Invivyd Analyst Ratings

BenzingaNov 14 17:05 ET

Invivyd Initiated at Buy by EF Hutton

Dow JonesOct 30 09:14 ET

EF Hutton Initiates Coverage On Invivyd With Buy Rating, Announces Price Target of $9

BenzingaOct 30 09:04 ET

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5

Moomoo NewsOct 29 18:31 ET

Invivyd Analyst Ratings

BenzingaOct 29 13:32 ET

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5

Moomoo NewsSep 24 07:31 ET

Buy Rating Affirmed for Invivyd: Strong Product Performance and Strategic Market Initiatives

TipRanksSep 9 06:31 ET

Buy Rating on Invivyd Backed by Strong Phase 3 Data and Market Catalysts

TipRanksAug 28 06:31 ET

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5

Moomoo NewsAug 28 06:31 ET

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and Invivyd (IVVD)

TipRanksAug 28 03:48 ET

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $15 Price Target

BenzingaAug 27 12:37 ET

Invivyd Analyst Ratings

BenzingaAug 27 12:37 ET

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Cuts Target Price to $9.5

Moomoo NewsAug 20 03:31 ET

Invivyd Analyst Ratings

BenzingaMay 24 12:51 ET

Invivyd Analyst Ratings

BenzingaMay 14 12:37 ET